Clinical Non-Inferiority of Pancreatic Enzymes (Norzyme ® - Bergamo) Compared To Creon ® (Solvay Pharmaceutical) in Patients With Exocrine Pancreatic Insufficiency

NCT01012908 · clinicaltrials.gov ↗

PHASE2,PHASE3

Phase

UNKNOWN

Status

25

Enrollment

INDUSTRY

Sponsor class

Conditions

Pancreatic Insufficiency

Interventions

DIETARY_SUPPLEMENT: Norzyme - Bergamo
DIETARY_SUPPLEMENT: Creon

Sponsor

Azidus Brasil